Thrivent Financial For Lutherans Caribou Biosciences, Inc. Transaction History
Thrivent Financial For Lutherans
- $45.7 Billion
- Q2 2025
A detailed history of Thrivent Financial For Lutherans transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 274,485 shares of CRBU stock, worth $628,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
274,485
Previous 274,485
-0.0%
Holding current value
$628,570
Previous $250,000
38.4%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
43.9MCall Options Held
25KPut Options Held
53.2K-
Black Rock Inc. New York, NY6.95MShares$15.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$9.37 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.07MShares$7.03 Million0.46% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.27MShares$5.2 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$4.14 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $139M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...